A 29-year-old man, who had been treated with potassium, spironolactone and indomethacin for over 9 years, was admitted because of nausea, vomiting, diarrhea and tetany manifestation. At the age of 20, he had been diagnosed as having Bartter's syndrome according to the criteria of the Japanese Ministry of Health and Welfare. Findings on admission were hypokalemia, hypomagnesemia and hypocalciuria. Renal distal fractional reabsorption rates of sodium, chloride and calcium were markedly decreased by administration of furosemide but there was no obvious change with administration of thiazide. These findings indicate that the patient had Gitelman's syndrome rather than Bartter's syndrome.
Introduction
Recently, Gitleman's syndrome (1) is represented in the reappraisal of Bartter-like syndrome (2) in Japan (3) (4) (5) . The syndromehas similar manifestations as those shownin sometypes of Bartter's syndrome (3) (4) (5) (6) . To distinguish the two syndromes, analyses of the change in urinary excretion of sodium, chloride, calcium and magnesium before and after administration of furosemide or thiazide (tests of furosemide and thiazide) are useful (3) (4) (5) . Wereport a case of Gitleman's syndrome revealed by the two tests of furosemide and thiazide, which had been diagnosed as Bartter's syndrome many years previously.
Case Report
First admission A 20-year-old manwas admitted to the NagaokaRed Cross Hospital because of nausea, vomiting and diarrhea, and tetany manifestation in February 1990. His family history is unknown.
On admission, his height was 173 cm and his weight was 51 kg. His blood pressure was 130/80 mmHg, and pulse rate was regular at 98/min. There were no abnormal signs except tetany manifestation. He had alkalosis (pH 7.6), hypokalemia (K 1.8 mEq//) and hypomagnesemia (Mg 1.3 mg/dl). Serum concentrations of total protein (8. 1 g/dl) and Ca (9.0 mg/dl) were normal and urinary Ca concentration was not measured. Plasma renin activity and plasma aldosterone concentration were high ( Table 1 ). The response of blood pressure for infusion of angiotensin II was low, but normalized after infusion of isotonic saline. Urinary excretion of prostaglandin E was high (Table  1) . Renal distal chloride fraction rate (0.62: normal range 0.8-0.92) was low. These laboratory data fulfilled the criteria reported by Research Group of the Japanese Ministry of Health and Welfare for the diagnosis of Bartter's syndrome (7) ( Table  2 ), although he also showedhypomagnesemia. He was treated with potassium, spironolactone and indomethacin. The serum potassium level was increased to 3. 1 mEq// following the treatment.
Second admission
At the age of 29 he was readmitted to the hospital because of nausea, vomiting and diarrhea, and tetany manifestation; as the symptomswere the same as the first admission in April 1999, he received the same medications as on the first admission. On admission, his height was 173 cm and his weight was 70 kg. His blood pressure was 126/80 mmHg, and pulse rate was regular at 80/min. There were no remarkable abnormal signs. General laboratory findings showed hypokalemia (K 2.4 mEq//) with U wave in ECGand hypomagnesemia (Mg 1.0 mg/dl), and no other abnormalities. Serum concentrations of total cholesterol (198 mg/dl), HDL (41 mg/dl) and LDL (91 mg/dl) were normal, although fasting serum triglyceride concentration (3 18 mg/dl) was high. Blood gas was normal. Plasma concentrations of active renin and aldosterone were high (Table  1) . Serum Ca concentration was 9.7 mg/dl, when the total protein level was 7.4 g/dl and urinary Ca concentration was 0.7 mg/dl. The ratio (0.01) of calcium (mg/dl)/creatinine (mg/dl) in urine was low, indicating that he might have Gitleman's syndrome (8) . To confirm this hypothesis, we performed the two tests of furosemide and thiazide (3) (4) (5) . First, water (20 ml/kg of body weight) was administered orally and then 0.45% saline wasinfused intravenouslyat a rate of 5 ml/min.After the urinary volumereached a constant value of greater than 5 ml/ min, wemeasuredthe renal clearance of Na, Cl, Ca and Mg (CNa, CC1,CCaand CMg)for 20 minutes for three times. Afterward, 20 mgof furosemide was administered intravenously andweremeasuredthe sameclearances. Second,as in the first procedurewemeasured the clearancesbeforeandafter oral administration of 100 mgthiazide. Ontwo tests, we further estimated the renal distal fractional reabsorption rate (%) (DFRR)of Na, Cl, Ca and Mgusing these clearances, which were calculated as [CH2O/CH2O+CNa, CC1, CCaor CMg.]xl 00. Asa result, the DFRR of Na, Cl and Caafter administrationof furosemidedecreased prominently, although there wasno change in the DFRRof Mg (Fig. 1) . The DFRRofNa, Cl and Caafter administrationof thiazide, however did not changeas those after administrationof furosemide, whereasthe DFRR of Mgwas obviously decreased (Fig. 2) . The findings indicated that the patient had Gitleman'ssyndrome rather than Bartter's syndrome (3) (4) (5) . In fact, the hypokalemiaand the hypomagnesemiawere improved to 3.3 mEq/l and 1.7 mg/dl, respectively, after oral administration of 3.7g of MgCl2with-out spironolactone or indomethacin,and his symptoms disappearedcompletely.SerumCaconcentrationwasnot altered, and serumconcentrations of intact PTH,related PTHand calcitonin werenormal (Table l) .Since Gitleman's syndromeis due to the gene abnormalityof thiazide-responsive-Na-Cl cotransporter (TSC) (9-1 1), the gene sequence is currently under analysis.
Gitelman's Syndrome and Bartter's Syndrome Time (minute) Figure 2 . The change in renal distal fractional reabsorption rate of sodium, chloride, calcium or magnesium before and after oral administration of 100 mg thiazide. The method is shown in the text.
Discussion
Gitelman et al first reported Gitleman's syndrome in 1966 ( 1) . The characteristic manifestations are normotension, hypokalemia, metabolic alkalosis, hyperreninemia, hyperaldosteronemia and hyperplasia of the juxtaglomerular apparatus such as those observed in Bartter's syndrome (1-7) ( Table 2 ). In addition, Gitleman's syndromeshows hypomagnesemiaand hypocalciuria. To distinguish the two syndromes, hypocalciuria is an important factor (Table 2 ). Bettinelli A et al reported that the ratio of urinary calcium (mg/dl)/creatinine I (mg/dl) in patients with Bartter's syndrome is higher than 0.265, whereas that in patients with Gitleman's syndrome is less than 0.265 (8) . However, some patients have overlapping values in the ratio of urinary calcium/creatinine. To distinguish the two forms, the usefulness of the furosemide test and thiazide test has been reported (3) (4) (5) . Recently, Bartter's syndrome is classified into three forms. The first form is due to the gene abnormality of renal bumetanide-sensitive Na-K-2C1 cotransporter ( 1 2). The second form is from the gene abnormality of ATP-sensitive K channel (13) . And the third form is due to the gene abnormality of renal chloride channel Kb (14) . Meanwhile, Gitelman's syndrome is due to the gene abnormality of TSC (9-ll). Accordingly, Gitelman's syndromeshows a response to the furosemide test, while Bartter's syndromehas no or little response for the furosemide test (Table 2 ) (3-5). In contrast, Gitelman's syndromehas no or little response to the thiazide test, while Bartter's syndromeshowsa response to the thiazide test (Table  2 ) (3) (4) (5) . In this case, although Bartter's syndrome was initially diagnosed, Gitelman's syndrome was conclusively demonstrated by the two tests as in the case reported by Tsukamoto et al (3) . As the third form of Bartter's syndrome, in particular, has clinical characteristics whichresemble those observed in Gitelman's syndrome (14) , some patients who had been diagnosed as having Bartter's syndrome based on the criteria of Bartter's syndrome defined by the Japanese Ministry of Health and Welfare (7) may truly have Gitelman's syndrome as in the present case (Table 2) . It is thus necessary to reconsider the criteria of Bartter's syndrome by the Japanese Ministry of Health and Welfare.
